The natural compound 2,3,5,4′-tetrahydroxystilbene-2-O-β-d glucoside protects against adriamycin-induced nephropathy through activating the Nrf2-Keap1 antioxidant pathway

2,3,4′,5-tetrahydroxystilbene-2-O-β-d-glucoside exerts anti-inflammatory effects on lipopolysaccharide-stimulated microglia by inhibiting NF-κB and activating AMPK/Nrf2 pathways

(2016) Sun Young Park et al.   FOOD AND CHEMICAL TOXICOLOGY

2,3,5,4′-Tetrahydroxystilbene-2-O-β-glucoside Isolated from Polygoni Multiflori Ameliorates the Development of Periodontitis

(2016) Yu-Tang Chin et al.   MEDIATORS OF INFLAMMATION

Biological Activities of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-Glucoside in Antiaging and Antiaging-Related Disease Treatments

(2016) Shuang Ling et al.   Oxidative Medicine and Cellular Longevity

Lowering cholesterol in chronic kidney disease: is it safe and effective?

(2015) M. G. Wong et al.   EUROPEAN HEART JOURNAL

Aortic Remodelling Is Improved by 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside Involving the Smad3 Pathway in Spontaneously Hypertensive Rats

(2015) Ju Duan et al.   Evidence-based Complementary and Alternative Medicine

Sulforaphane prevents doxorubicin-induced oxidative stress and cell death in rat H9c2 cells

(2015) BO LI et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Proliferation of rat cardiac stem cells is induced by 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-d-glucoside in vitro

(2015) Fan Song et al.   LIFE SCIENCES

The Pathogenesis of Focal Segmental Glomerulosclerosis

(2014) J. Ashley Jefferson et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis

(2014) Ilse Daehn et al.   JOURNAL OF CLINICAL INVESTIGATION

Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal

(2014) Antonio Ayala et al.   Oxidative Medicine and Cellular Longevity

Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway

(2013) Ai-Mei Gao et al.   CARCINOGENESIS

Heme oxygenase-1 and acute kidney injury

(2013) Karl A. Nath   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease

(2013) Stacey Ruiz et al.   KIDNEY INTERNATIONAL

Immunosuppressive treatment in primary focal segmental glomerulosclerosis

(2012) Shizhang Xu et al.   JOURNAL OF NEPHROLOGY

2, 3, 5, 4′-Tetrahydroxystilbene-2-O-Beta-D-Glucoside Improves Gastrointestinal Motility Disorders in STZ-Induced Diabetic Mice

(2012) Mu-Jun Chang et al.   PLoS One

Role of Intrarenal Angiotensin System Activation, Oxidative Stress, Inflammation, and Impaired Nuclear Factor-Erythroid-2-Related Factor 2 Activity in the Progression of Focal Glomerulosclerosis

(2011) H. J. Kim et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells

(2010) Sarala Manandhar et al.   ARCHIVES OF PHARMACAL RESEARCH

Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: Involvement of SIRT1 and TGF-β1 pathway

(2010) Cairong Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Adriamycin nephropathy: A model of focal segmental glomerulosclerosis

(2010) VINCENT WS LEE et al.   NEPHROLOGY

Pathogenesis and therapy of focal segmental glomerulosclerosis: an update

(2010) Rasheed Gbadegesin et al.   PEDIATRIC NEPHROLOGY

Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo

(2009) Shao-hui Zhang et al.   ACTA PHARMACOLOGICA SINICA

Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events

(2008) Chia-Chao Wu et al.   LABORATORY ANIMALS

2,3,4',5-TETRAHYDROXYSTILBENE-2-O-β-d-GLUCOSIDE SUPPRESSES MATRIX METALLOPROTEINASE EXPRESSION AND INFLAMMATION IN ATHEROSCLEROTIC RATS

(2007) Wei Zhang et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY